Autoimmune Therapy Without Immunosuppression – Saad Harti, CEO & Founder | Legacy Healthcare скачать в хорошем качестве

Autoimmune Therapy Without Immunosuppression – Saad Harti, CEO & Founder | Legacy Healthcare

Saad Harti presents Legacy Healthcare’s breakthrough approach to chronic autoimmune disease: FDA-regulated botanical drugs that deliver clinical efficacy without immunosuppression or long-term safety trade-offs. Using SINU, a multi-plant extract therapy for alopecia areata, as a case study, he explains why chronic diseases require multi-target treatments rather than single-molecule drugs—and how edible, clinically validated plant extracts can achieve durable, disease-modifying effects. Phase II data showed sustained efficacy after treatment cessation, exemplary safety, and no immune suppression, positioning the therapy as a first-line option for physicians and payers alike. With FDA clearance to enter Phase III, patent protection through 2043, and a projected multi-billion-dollar peak market, Harti frames botanical drugs not as “alternative medicine,” but as the next platform shift in pharma—aligned with longevity, sustainability, and patient trust. About the Speaker: Saad Harti is a healthcare entrepreneur with a background in marketing, audit, and M&A. He founded AltaCare, expanding mid-size pharma sales to 60+ countries, and later created Legacy Healthcare to develop prescription botanical drugs, including a Phase 2–validated therapy for autoimmune disease. Originally from Morocco, he lives in Switzerland and is a triathlete.